238 related articles for article (PubMed ID: 34869350)
1. A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
Huo J; Cai J; Guan G; Liu H; Wu L
Front Cell Dev Biol; 2021; 9():761839. PubMed ID: 34869350
[No Abstract] [Full Text] [Related]
2. A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma.
Huo J; Fan X; Qi B; Sun P
Front Genet; 2022; 13():771819. PubMed ID: 35126478
[No Abstract] [Full Text] [Related]
3. Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma.
Huo J; Cai J; Wu L
Cancer Med; 2023 Jan; 12(1):898-912. PubMed ID: 35651292
[TBL] [Abstract][Full Text] [Related]
4. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
Wan S; Lei Y; Li M; Wu B
Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
[TBL] [Abstract][Full Text] [Related]
5. DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.
Shang Z; Wang Z; Zhang Y; Liu S
Transl Cancer Res; 2023 Oct; 12(10):2781-2805. PubMed ID: 37969400
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
Front Genet; 2022; 13():823443. PubMed ID: 35368686
[No Abstract] [Full Text] [Related]
7. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.
Ren H; Zheng J; Cheng Q; Yang X; Fu Q
Front Genet; 2022; 13():900713. PubMed ID: 35957699
[No Abstract] [Full Text] [Related]
9. A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Huo J; Wu L; Zang Y
Front Mol Biosci; 2020; 7():581354. PubMed ID: 33282911
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
[TBL] [Abstract][Full Text] [Related]
11. A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma.
Chen Y; Zhu Y; Dong Y; Li H; Gao C; Zhu G; Mi X; Li C; Xu Y; Wang G; Cai S; Han Y; Xu C; Wang W; Yang S; Ji W
Front Oncol; 2023; 13():1085188. PubMed ID: 37051536
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma.
Ding J; He X; Luo W; Zhou W; Chen R; Cao G; Chen B; Xiong M
Front Genet; 2022; 13():801419. PubMed ID: 35140750
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.
Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
J Gastrointest Oncol; 2021 Oct; 12(5):2345-2360. PubMed ID: 34790397
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
Front Oncol; 2021; 11():755212. PubMed ID: 34804944
[TBL] [Abstract][Full Text] [Related]
15. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
[TBL] [Abstract][Full Text] [Related]
16. Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Yu J; Chen Y; Pan X; Wen W
Oxid Med Cell Longev; 2022; 2022():3713929. PubMed ID: 36246400
[TBL] [Abstract][Full Text] [Related]
17. The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.
Liu Z; Wang L; Liu L; Lu T; Jiao D; Sun Y; Han X
Front Oncol; 2021; 11():619242. PubMed ID: 33738257
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
19. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
[TBL] [Abstract][Full Text] [Related]
20. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer.
Chen Q; Jun H; Yang C; Yang F; Xu Y
J Oncol; 2022; 2022():3625790. PubMed ID: 36059808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
